Sorafenib, a clinical kinase inhibitor, attenuates Streptococcus pneumoniae pathogenesis and reduces disease progression in vivo. (journals.asm.org)

Authors: Abraham J … Subramanian K Journal: mBio Published: 2026-06-16 DOI: https://doi.org/10.1128/mbio.00618-26